Related Experiment Video
Updated: Nov 30, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Use of a Procalcitonin-guided Antibiotic Treatment Algorithm in the Pediatric Intensive Care Unit
Sophie E Katz1, Jennifer Crook1,2, Jessica Gillon3
1From the Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN.
Insights
Procalcitonin testing did not reduce antibiotic use in critically ill children. However, this study demonstrated the feasibility of a procalcitonin-guided antibiotic treatment algorithm in the pediatric intensive care unit (PICU).
Area of Science:
- Pediatric critical care medicine
- Infectious disease management
- Clinical trial methodology
Background:
- The effectiveness of procalcitonin testing in guiding antibiotic therapy within the pediatric intensive care unit (PICU) remains uncertain.
- Antibiotic stewardship (AS) is crucial for optimizing antimicrobial use in pediatric intensive care settings.
- Critically ill children often receive broad-spectrum antibiotics, necessitating strategies to reduce unnecessary exposure.
Purpose of the Study:
- To evaluate the impact of a procalcitonin-guided antibiotic treatment algorithm, combined with AS, on antibiotic utilization in critically ill children.
- To compare antibiotic days of therapy (DOT) between a procalcitonin-guided arm and a usual care arm in the PICU.
- To assess the feasibility of implementing a procalcitonin-based algorithm within a pediatric intensive care environment.
Main Methods:
- A single-center, pragmatic, randomized prospective clinical trial was conducted involving critically ill children receiving intravenous antibiotics.
- Patients were assigned monthly to either a procalcitonin testing arm or a usual care arm.
- The procalcitonin arm involved daily testing and AS interpretation, while both arms received routine AS audit and feedback.
Main Results:
- No significant difference in median antibiotic DOT was observed between the procalcitonin arm (6.6 days) and the usual care arm (7.6 days) within the first 14 days (P=0.37).
- The procalcitonin arm saw a higher number of antibiotic stewardship recommendations (54 vs. 37; P=0.03).
- Adherence to algorithm-based antibiotic recommendations in the procalcitonin arm was high at 70%.
Conclusions:
- The study found no significant reduction in antibiotic DOT using a procalcitonin-guided algorithm in the PICU.
- While underpowered, the trial successfully demonstrated the feasibility of implementing a procalcitonin-guided antibiotic treatment algorithm with AS support in critically ill children.
- Further research with larger sample sizes is warranted to confirm the clinical utility of procalcitonin in this population.
Background:
The utility of procalcitonin testing in the pediatric intensive care unit (PICU) is not known. We sought to determine the impact of a procalcitonin-guided antibiotic treatment algorithm implemented with antibiotic stewardship (AS) guidance vs. usual care on antibiotic use in critically ill children.
Methods:
Single center, pragmatic, randomized prospective clinical trial of critically ill children admitted to an ICU setting and started on intravenous antibiotics from February 15, 2018, to April 11, 2019. Patients were assigned on a monthly basis to either the procalcitonin or usual care arm. The procalcitonin arm had procalcitonin testing on hospital days 0, 1, 2, and 4 and stewardship assistance with algorithm result interpretation. Both arms had routine AS audit and feedback. The primary outcome was median antibiotic days of therapy per patient in the first 14-days after enrollment.
Results:
Among 270 patients, 137 were in the procalcitonin arm and 133 in the usual care arm. Antibiotic days of therapy (DOT) were not significantly different between the procalcitonin arm (6.6, IQR: 3.1-10.9) and the usual care arm (7.6, IQR: 3-11.8; P = 0.37). More AS recommendations were made in the procalcitonin vs. control arm (54 vs. 37; P = 0.03). Adherence with algorithm-based antibiotic recommendations was high in the procalcitonin arm (70%).
Conclusions:
We found no difference in antibiotic DOT between study arms. This trial was underpowered but demonstrates feasibility of using a procalcitonin-guided antibiotic treatment algorithm with AS audit and feedback in the PICU.
More Related Videos
06:18Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software
Published on: December 14, 2020
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pneumonia III: Complications and Assessment
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test